Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in youngsters and adults . In Canada, its distribution is managed by Health Canada. https://lisdexamfetamineshopinca494035.ampedpages.com/vyvanse-in-canada-a-comprehensive-guide-70287448